Initial trials of precision medicine approaches in airway disease

V. McDonald (Newcastle, Australia)

Source: ERS Research Seminar 2017 – Precision medicine in airway diseases
Number: 4
Disease area: Airway diseases

PDF journal article, handout or slidesSlide presentation

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. McDonald (Newcastle, Australia). Initial trials of precision medicine approaches in airway disease. ERS Research Seminar 2017 – Precision medicine in airway diseases

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

Roberto Enrique Díaz García - 19.08.2017 02:44
Excelente

You must Login to comment this presentation.


Related content which might interest you:
Precision medicine in airway diseases: moving to clinical practice
Source: Eur Respir J, 50 (4) 1701655; 10.1183/13993003.01655-2017
Year: 2017



Triple therapy trials in COPD: a precision medicine opportunity
Source: Eur Respir J, 52 (6) 1801848; 10.1183/13993003.01848-2018
Year: 2018



Linking clinical algorithms to precision medicine
Source: Virtual Congress 2020 – Precision endotyping of asthma: time for action
Year: 2020


Efficiency of different strategies of asthma control achievement in real clinical practice
Source: Annual Congress 2011 - Asthma: control and treatment
Year: 2011


Towards individualised medicine for airways disease: identifying clinical phenotype groups
Source: Eur Respir J 2012; 39: 1033-1034
Year: 2012


Comparative efficacy of the therapy strategies for the asthma control maintenance in real clinical practice
Source: Annual Congress 2011 - Asthma: control and treatment
Year: 2011


Methodological issues in therapeutic trials of COPD
Source: Eur Respir J 2008; 31: 927-933
Year: 2008



Emerging concepts in outcome assessment for COPD clinical trials
Source: Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease
Year: 2007

How to increase the value of randomised trials in COPD research
Source: Eur Respir J 2009; 34: 552
Year: 2009



NOVELTY: a landmark study in phenotyping and endotyping chronic obstructive airway diseases in real clinical practice
Source: Eur Respir J, 58 (3) 2100627; 10.1183/13993003.00627-2021
Year: 2021



New and future developments of therapy for asthma in children
Source: Eur Respir Mon 2012; 56: 224-234
Year: 2012


New clinical research strategies in thoracic oncology: clinical trial design, adaptive, basket and umbrella trials, new end-points and new evaluations of response
Source: Eur Respir Rev 2014; 23: 367-378
Year: 2014



Effectiveness of different models of maintenance therapy for bronchial asthma (BA) in routine clinical practice
Source: Eur Respir J 2007; 30: Suppl. 51, 70s
Year: 2007

Comparative assessment of the qol specific parameters in children with bronchial asthma with standard pharmacotherapy, and in additional course of physiotherapy in the pool
Source: International Congress 2018 – Pulmonary rehabilitation: exercise training, body composition, physical activity and other aspects
Year: 2018

Treatable traits: toward precision medicine of chronic airway diseases
Source: Eur Respir J 2016; 47: 410-419
Year: 2016



Measuring airway hyperresponsiveness: does it add to routine measures of clinical efficacy in guiding asthma therapy?
Source: Eur Respir J 2006; 28: Suppl. 50, 319s
Year: 2006

A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials
Source: Eur Respir J 2015; 46: 243-249
Year: 2015



Assessing the effect of medical therapy in COPD: from pathophysiology and biomarkers to clinical practice
Source: Annual Congress 2009 - PG15 The complexity of COPD: assessment and advanced therapies
Year: 2009



Managing the challenges of spirometry in multi center clinical trials
Source: Annual Congress 2010 - Management of airway disease
Year: 2010